Download PDF
Int J Angiol 2023; 32(02): 106-112
DOI: 10.1055/s-0042-1742308
Original Article

Relationship between Hemoglobin Concentration at Admission with the Incidence of No-Reflow Phenomenon and In-Hospital Mortality in Acute Myocardial Infarction with Elevation of ST Segments in Patients who underwent Primary Percutaneous Coronary Intervention

Kiagus Muhammad Andri Akbar
1   Department of Cardiology and Vascular Medicine, Faculty of Medicine, Universitas Indonesia/National Cardiovascular Centre Harapan Kita, Jakarta, Indonesia
,
Surya Dharma 
1   Department of Cardiology and Vascular Medicine, Faculty of Medicine, Universitas Indonesia/National Cardiovascular Centre Harapan Kita, Jakarta, Indonesia
,
Hananto Andriantoro
1   Department of Cardiology and Vascular Medicine, Faculty of Medicine, Universitas Indonesia/National Cardiovascular Centre Harapan Kita, Jakarta, Indonesia
,
Renan Sukmawan
1   Department of Cardiology and Vascular Medicine, Faculty of Medicine, Universitas Indonesia/National Cardiovascular Centre Harapan Kita, Jakarta, Indonesia
,
Arwin Saleh Mangkuanom
1   Department of Cardiology and Vascular Medicine, Faculty of Medicine, Universitas Indonesia/National Cardiovascular Centre Harapan Kita, Jakarta, Indonesia
,
Vidya Gilang Rejeki
1   Department of Cardiology and Vascular Medicine, Faculty of Medicine, Universitas Indonesia/National Cardiovascular Centre Harapan Kita, Jakarta, Indonesia
› Author Affiliations
› Further Information
    Permissions and Reprints

Abstract

Anemia in acute ST-segment elevation myocardial infarction (STEMI) is associated with a pro-coagulant state, contributing to the incidence of no-reflow phenomenon and increased mortality following primary percutaneous coronary intervention (PPCI). However, clinical data remain contradictory. The objective of our study was to evaluate the association of admission hemoglobin (Hb) concentration and in-hospital mortality of STEMI patients' post-PPCI, as well as final thrombolysis in myocardial infarction (TIMI) flow. A cross-sectional study was performed from the database of Jakarta Acute Coronary Syndrome Registry, consisting of 3,071 STEMI patients who underwent PPCI between January 2014 and December 2019. No-reflow phenomenon was defined as final TIMI flow <3 of the infarct-related artery. Outcome measures were the occurrence of no-reflow and in-hospital mortality. Anemia criteria were based on the World Health Organization. Anemia was found in 550 patients (17.9%). Patients with anemia were older (60 ± 10 years, p < 0.001), predominantly women (20.7 vs. 11.2%, p < 0.001), TIMI risk score >4 (45.8 vs. 30.4%, p < 0.00), and Killip classification >1 (25.8 vs. 20.8%, p < 0.009). Anemia at admission was not associated with no-reflow phenomenon (odds ratio [OR] = 0.889; 95% confidence interval [CI] = 0.654–1.209, p = 0.455). Multivariate regression models showed that anemia was not associated with in-hospital mortality (OR = 0.963; 95% CI = 0.635–1.459, p = 0.857) and with no-reflow phenomenon (OR = 0.939; 95% CI = 0.361–2.437, p = 0.896). Anemia upon admission was not related to the no-reflow phenomena or in-hospital mortality in STEMI patients undergoing PPCI.

Keywords

Anemia - STEMI - PPCI - TIMI flow - Pro-coagulant state - No-reflow phenomenon - In-hospital mortality


Publication History

Article published online:
12 February 2022

© 2022. International College of Angiology. This article is published by Thieme.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 

  • Reference

  • 1 Kementerian Kesehatan RI. (2019, February 4). Hasil Utama Riset Kesehatan Dasar (RISKESDAS) 2018. Retrieved December 9, 2021, Available at: https://kesmas.kemkes.go.id/konten/105/0/020417-hasil-riskesdas-2018
    PubMedGoogle Scholar
  • 2 Harrison RW, Aggarwal A, Ou FS. et al; American College of Cardiology National Cardiovascular Data Registry. Incidence and outcomes of no-reflow phenomenon during percutaneous coronary intervention among patients with acute myocardial infarction. Am J Cardiol 2013; 111 (02) 178-184
    CrossrefPubMedGoogle Scholar
  • 3 Twomley KM, Rao SV, Becker RC. Proinflammatory, immunomodulating, and prothrombotic properties of anemia and red blood cell transfusions. J Thromb Thrombolysis 2006; 21 (02) 167-174
    CrossrefPubMedGoogle Scholar
  • 4 Rezkalla SH, Kloner RA. No-reflow phenomenon. Circulation 2002; 105 (05) 656-662
    CrossrefPubMedGoogle Scholar
  • 5 Nikolsky E, Aymong ED, Halkin A. et al. Impact of anemia in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: analysis from the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) Trial. J Am Coll Cardiol 2004; 44 (03) 547-553
    CrossrefPubMedGoogle Scholar
  • 6 Yaylak B, Altıntaş B, Özcan KS. et al. Relation of hemoglobin level to no-reflow in patients with ST-segment elevation myocardial infarction undergoing primary coronary intervention. Postepy Kardiol Interwencyjnej 2018; 14 (04) 383-390
    PubMedGoogle Scholar
  • 7 Karabulut A, Uyarel H, Uzunlar B, Çakmak M. Elevated red cell distribution width level predicts worse postinterventional thrombolysis in myocardial infarction flow reflecting abnormal reperfusion in acute myocardial infarction treated with a primary coronary intervention. Coron Artery Dis 2012; 23 (01) 68-72
    CrossrefPubMedGoogle Scholar
  • 8 Lawler PR, Filion KB, Dourian T, Atallah R, Garfinkle M, Eisenberg MJ. Anemia and mortality in acute coronary syndromes: a systematic review and meta-analysis. Am Heart J 2013; 165 (02) 143-53.e5
    CrossrefPubMedGoogle Scholar
  • 9 Ibanez B, James S, Agewall S, Antunes MJ, Bucciarelli-Ducci C, Bueno H, Caforio ALP, Crea F, Goudevenos JA, Halvorsen S, Hindricks G, Kastrati A, Lenzen MJ, Prescott E, Roffi M, Valgimigli M, Varenhorst C, Vranckx P, Widimský P. ESC Scientific Document Group. 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J 2018 Jan 7;39(2):119-177. Doi: 10.1093/eurheartj/ehx393. PMID: 28886621
    PubMedGoogle Scholar
  • 10 Moghaddam N, Wong GC, Cairns JA. et al. Association of anemia with outcomes among ST-segment-elevation myocardial infarction patients receiving primary percutaneous coronary intervention. Circ Cardiovasc Interv 2018; 11 (12) e007175
    CrossrefPubMedGoogle Scholar
  • 11 Sabatine MS, Morrow DA, Giugliano RP. et al. Association of hemoglobin levels with clinical outcomes in acute coronary syndromes. Circulation 2005; 111 (16) 2042-2049
    CrossrefPubMedGoogle Scholar
  • 12 Lee BY, Wilson GJDR, Domenech RJ, MacGregor DC. Relative roles of edema versus contracture in the myocardial postischemic “no-reflow” phenomenon. J Surg Res 1980; 29 (01) 50-61
    CrossrefPubMedGoogle Scholar
  • 13 Guo Y, Yin F, Fan C, Wang Z. Gender difference in clinical outcomes of the patients with coronary artery disease after percutaneous coronary intervention: a systematic review and meta-analysis. Medicine (Baltimore) 2018; 97 (30) e11644
    CrossrefPubMedGoogle Scholar
  • 14 Carrabba N, Santoro GM, Balzi D. et al; AMI-Florence Working Group. In-hospital management and outcome in women with acute myocardial infarction (data from the AMI-Florence Registry). Am J Cardiol 2004; 94 (09) 1118-1123
    CrossrefPubMedGoogle Scholar
  • 15 Dreyer RP, Ranasinghe I, Wang Y. et al. Sex differences in the rate, timing, and principal diagnoses of 30-day readmissions in younger patients with acute myocardial infarction. Circulation 2015; 132 (03) 158-166
    CrossrefPubMedGoogle Scholar
  • 16 Wang Z, Ren L, Lei L, Ye H, Peng J. The relationship between neutrophil counts on admission and angiographic no-reflow after primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction. Acta Cardiol 2016; 71 (02) 241-246
    CrossrefPubMedGoogle Scholar
  • 17 Kojima S, Sakamoto T, Ishihara M. et al; Japanese Acute Coronary Syndrome Study investigators. The white blood cell count is an independent predictor of no-reflow and mortality following acute myocardial infarction in the coronary interventional era. Ann Med 2004; 36 (02) 153-160
    CrossrefPubMedGoogle Scholar
  • 18 Olszowska M, Tracz W, Kostkiewicz M, Podolec P. Predictive factors of myocardial reperfusion in patients with anterior wall acute myocardial infarction. Cardiol J 2008; 15 (01) 57-62
    PubMedGoogle Scholar
  • 19 Giannitsis E, Müller-Bardorff M, Lehrke S, Wiegand U, Tölg R, Weidtmann B, Hartmann F, Richardt G, Katus HA. Admission troponin T level predicts clinical outcomes, TIMI flow, and myocardial tissue perfusion after primary percutaneous intervention for acute ST-segment elevation myocardial infarction. Circulation 2001 Aug 7;104(06):630–635. Doi: 10.1161/hc3101.093863. PMID: 11489766
    PubMedGoogle Scholar
  • 20 Hong SN, Ahn Y, Hwang SH. et al. Usefulness of preprocedural N-terminal pro-brain natriuretic peptide in predicting angiographic no-reflow phenomenon during stent implantation in patients with ST-segment elevation acute myocardial infarction. Am J Cardiol 2007; 100 (04) 631-634
    CrossrefPubMedGoogle Scholar
  • 21 Liu CW, Liao PC, Chen KC. et al. Baseline hemoglobin levels associated with one-year mortality in ST-segment elevation myocardial infarction patients. Acta Cardiol Sin 2016; 32 (06) 656-666
    PubMedGoogle Scholar
  • 22 Nallamothu BK, Bradley EH, Krumholz HM. Time to treatment in primary percutaneous coronary intervention. N Engl J Med 2007; 357 (16) 1631-1638
    CrossrefPubMedGoogle Scholar
  • 23 Tarantini G, Cacciavillani L, Corbetti F. et al. Duration of ischemia is a major determinant of transmurality and severe microvascular obstruction after primary angioplasty: a study performed with contrast-enhanced magnetic resonance. J Am Coll Cardiol 2005; 46 (07) 1229-1235
    CrossrefPubMedGoogle Scholar
  • 24 Gaskell H, Derry S, Andrew Moore R, McQuay HJ. Prevalence of anaemia in older persons: systematic review. BMC Geriatr 2008; 8: 1-8
    CrossrefPubMedGoogle Scholar
  • 25 Wilkerson WR, Sane DC. Aging and thrombosis. Semin Thromb Hemost 2002; 28 (06) 555-568
    Article in Thieme ConnectPubMedGoogle Scholar
  • 26 Franco RS, Puchulu-Campanella ME, Barber LA. et al. Changes in the properties of normal human red blood cells during in vivo aging. Am J Hematol 2013; 88 (01) 44-51
    CrossrefPubMedGoogle Scholar
  • 27 Parodi G, Valenti R, Carrabba N. et al. Long-term prognostic implications of nonoptimal primary angioplasty for acute myocardial infarction. Catheter Cardiovasc Interv 2006; 68 (01) 50-55
    CrossrefPubMedGoogle Scholar
  • 28 Thompson RC, Holmes Jr DR, Gersh BJ, Mock MB, Bailey KR. Percutaneous transluminal coronary angioplasty in the elderly: early and long-term results. J Am Coll Cardiol 1991; 17 (06) 1245-1250
    CrossrefPubMedGoogle Scholar
  • 29 Park HW, Han S, Park GM. et al. Sex-related impacts on clinical outcomes after percutaneous coronary intervention. Sci Rep 2020; 10 (01) 15262
    CrossrefPubMedGoogle Scholar
  • 30 Ndrepepa G, Tiroch K, Fusaro M. et al. 5-year prognostic value of no-reflow phenomenon after percutaneous coronary intervention in patients with acute myocardial infarction. J Am Coll Cardiol 2010; 55 (21) 2383-2389
    CrossrefPubMedGoogle Scholar
  • 31 Celik T, Balta S, Mikhailidis DP. et al. The relation between no-reflow phenomenon and complete blood count parameters. Angiology 2017; 68 (05) 381-388
    CrossrefPubMedGoogle Scholar